Neuphoria Therapeutics Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NEUP and other ETFs, options, and stocks.About NEUP
Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor.
NEUP Key Statistics
Stock Snapshot
As of today, Neuphoria Therapeutics Inc.(NEUP) shares are valued at $3.44. The company's market cap stands at 18.59M, with a P/E ratio of -0.14.
As of 2026-07-06, Neuphoria Therapeutics Inc.(NEUP) stock has fluctuated between $3.30 and $3.59. The current price stands at $3.44, placing the stock +4.2% above today's low and -4.2% off the high.
The Neuphoria Therapeutics Inc.(NEUP)'s current trading volume is 65.26K, compared to an average daily volume of 140.15K.
During the past year, Neuphoria Therapeutics Inc.(NEUP) stock moved between $3.19 at its lowest and $21.40 at its peak.
During the past year, Neuphoria Therapeutics Inc.(NEUP) stock moved between $3.19 at its lowest and $21.40 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.